Émilie Bortolussi-Courval, Tiina Podymow, Marisa Battistella, Emilie Trinh, Thomas A Mavrakanas, Lisa McCarthy, Joseph Moryousef, Ryan Hanula, Jean-François Huon, Rita Suri, Todd C Lee, Emily G McDonald
RATIONALE & OBJECTIVE: Patients treated with dialysis are commonly prescribed multiple medications (polypharmacy), including some potentially inappropriate medications (PIMs). PIMs are associated with an increased risk of medication harm (eg, falls, fractures, hospitalization). Deprescribing is a solution that proposes to stop, reduce, or switch medications to a safer alternative. Although deprescribing pairs well with routine medication reviews, it can be complex and time-consuming...
May 2024: Kidney medicine